Two Sigma Investments’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-159,154
| Closed | -$5.62M | – | 3093 |
|
|
2024
Q2 | $5.62M | Buy |
159,154
+150,242
| +1,686% | +$5.3M | 0.01% | 902 |
|
|
2024
Q1 | $253K | Buy |
+8,912
| New | +$253K | ﹤0.01% | 2555 |
|
|
2023
Q4 | – | Sell |
-24,400
| Closed | -$219K | – | 3118 |
|
|
2023
Q3 | $219K | Sell |
24,400
-8,100
| -25% | -$72.6K | ﹤0.01% | 2531 |
|
|
2023
Q2 | $366K | Sell |
32,500
-126,487
| -80% | -$1.42M | ﹤0.01% | 2385 |
|
|
2023
Q1 | $1.83M | Buy |
158,987
+3,638
| +2% | +$41.9K | 0.01% | 1365 |
|
|
2022
Q4 | $1.8M | Buy |
155,349
+138,325
| +813% | +$1.6M | 0.01% | 1315 |
|
|
2022
Q3 | $216K | Buy |
+17,024
| New | +$216K | ﹤0.01% | 2033 |
|
|
2022
Q2 | – | Sell |
-26,722
| Closed | -$258K | – | 2551 |
|
|
2022
Q1 | $258K | Sell |
26,722
-101,007
| -79% | -$975K | ﹤0.01% | 2228 |
|
|
2021
Q4 | $1.52M | Buy |
127,729
+14,525
| +13% | +$173K | ﹤0.01% | 1465 |
|
|
2021
Q3 | $1.84M | Buy |
+113,204
| New | +$1.84M | ﹤0.01% | 1403 |
|
|
2021
Q2 | – | Sell |
-26,000
| Closed | -$404K | – | 2519 |
|
|
2021
Q1 | $404K | Buy |
+26,000
| New | +$404K | ﹤0.01% | 1953 |
|